Missouri judge approves Bayer’s $7.25 billion Roundup settlement
+1 new source since this summary was written
A Missouri judge gave final approval to Bayer AG’s proposal to pay up to $7.25 billion to settle U.S. lawsuits alleging its Roundup weedkiller causes cancer. The settlement covers roughly 65,000 current and future claims and offers payouts ranging from $10,000 to $165,000 per claimant. Bayer had previously spent about $10 billion in 2020 on earlier Roundup litigation and had been unable to secure court approval for a $1.25 billion parallel settlement. The approval follows a recent Supreme Court ruling in Bayer’s favor and a jury verdict that lifted the company’s shares.
Why it matters
The settlement caps Bayer’s future liability for Roundup cancer claims, removing a major legal uncertainty and potentially supporting its share price. The company will need to fund payouts of up to $7.25 billion, which will affect cash flow and balance‑sheet allocations.
Key facts
- 1A Missouri judge approved Bayer’s $7.25 billion settlement of Roundup cancer lawsuits. investing.com
- 2The settlement aims to resolve approximately 65,000 claims in U.S. state and federal courts. investing.com
- 3Payouts under the deal range from $10,000 to $165,000 per claimant. investing.com
- 4Bayer previously spent about $10 billion in 2020 to resolve most existing Roundup lawsuits. investing.com
- 5Bayer was unable to obtain court approval for a $1.25 billion settlement that would have covered future claims. investing.com
- 6Bayer’s shares rose after a recent jury verdict in its favor. finance.yahoo.com
Summary written by AlphAI AI Desk from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.